NCT02971046

Brief Summary

To measure the fractional and absolute synthesis rates of GSH, an antioxidant that protects cells from damage, in the erythrocytes of healthy school-aged children, young adults and old adults in response to graded intakes of protein in order to determine if increasing the protein intake above the current recommended DRI produces increases in the GSH synthesis rates in erythrocytes of these individuals. Participants will consume specially formulated diets with varying protein levels.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
18mo left

Started Oct 2020

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Oct 2020Nov 2027

First Submitted

Initial submission to the registry

November 11, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 22, 2016

Completed
3.9 years until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

7.2 years

First QC Date

November 11, 2016

Last Update Submit

May 23, 2025

Conditions

Keywords

healthy childrenproteinglutathioneprotein requirementhealthy young adultshealthy adults over 60 years of age

Outcome Measures

Primary Outcomes (1)

  • Erythrocyte GSH Fractional synthesis rates

    To measure the fractional synthesis rates of GSH in the erythrocytes of healthy school-aged children and healthy young and old adults in response to graded intakes of protein.

    up to 24 months

Secondary Outcomes (1)

  • Erythrocyte GSH absolute synthesis

    up to 24 months

Study Arms (1)

Protein intake

EXPERIMENTAL

Varying protein intakes.

Other: varying protein intakes

Interventions

In healthy school-aged children: Four randomly assigned levels of protein intake in a repeated measured design. The levels of protein intake are 0.95, 1.3,1.55, and 2.0 grams per kilogram of bodyweight per day. In healthy young and old adults: Up to six randomly assigned levels of protein intake in a repeated measured design. The levels of protein intake are : 0.66, 0.8, 1, 1.2, and 1.5 grams per kilogram of bodyweight per day.

Protein intake

Eligibility Criteria

Age6 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy school-aged children
  • Body weight ≥ 22 kg
  • No history of anemia
  • Willingness to participate
  • Healthy Young Adults
  • Consent provided
  • Aged 19 - 40 years old
  • In good general health as evidenced by medical history, physical health and blood draw
  • Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine, vitamin-B6, vitamin-B12 and folate levels within normal ranges for age.
  • Willingness to participate in the study.
  • BMI \<25 kg/m2.
  • Healthy Old Adults
  • Consent provided
  • Aged 60- 90 years old
  • In good general health as evidenced by medical history, physical health and blood draw
  • +3 more criteria

You may not qualify if:

  • Healthy school-aged children
  • HIV
  • Diabetes
  • Anaemia
  • Significant weight loss within 30 days of study
  • On weight loss diets
  • Body weight less that 22kg
  • Inability to tolerate diet
  • Unwilling to have blood drawn
  • Healthy Young and Old Adults:
  • Presence of chronic disease and/or acute illness known to affect GSH and/or protein/amino acid metabolism (e.g. HIV, diabetes, cancer, liver or kidney disease, acute cold or flu).
  • Anemia (15 - 20% outside lower limit of normal lab reference ranges)
  • Taking medications known to affect GSH and/or protein/AA metabolism (e.g. acetaminophen, steroids).
  • Significant weight loss during the past month or consumption of weight reducing diets.
  • Significant caffeine consumption (\>2 cups per day).
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

Related Publications (2)

  • Paoletti A, Pencharz PB, Rafii M, Tomlinson C, Kong D, Xu L, Elango R, Courtney-Martin G. Protein intake affects erythrocyte glutathione synthesis in healthy adults aged >/=60 years in a repeated-measures trial. Am J Clin Nutr. 2024 Apr;119(4):917-926. doi: 10.1016/j.ajcnut.2024.02.002. Epub 2024 Feb 5.

  • Szwiega S, Xu L, Rafii M, Pencharz PB, Kong D, Tomlinson C, Elango R, Courtney-Martin G. Protein intake affects erythrocyte glutathione synthesis in young healthy adults in a repeated-measures trial. Am J Clin Nutr. 2024 Feb;119(2):371-383. doi: 10.1016/j.ajcnut.2023.11.008. Epub 2023 Nov 20.

Study Officials

  • Glenda Courtney-Martin, PhD

    Academic &Clinical Specialist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Academic &Clinical Specialist, Project Investigator

Study Record Dates

First Submitted

November 11, 2016

First Posted

November 22, 2016

Study Start

October 1, 2020

Primary Completion (Estimated)

November 30, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations